13-valent pneumococcal conjugate vaccine (Suzhou Vacmicro Biotech）

13价肺炎球菌结合疫苗（苏州微超生物科技）

Report date: 2022/01/15 15:55:01

Base Information

Drug Name13-valent pneumococcal conjugate vaccine (Suzhou Vacmicro Biotech）

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSepsisPneumonia, BacterialPneumonia, Pneumococcal +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesSuzhou Vacmicro Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Vacmicro Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsSepsisPneumonia, BacterialPneumonia, Pneumococcal +[6]

Inactive IndicationsN/A

Other Information

ATC CodeN/A